On January 9, 2023 Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, reported that Robert E. Hoffman, President and CEO of Kintara, will be presenting at the Biotech Showcase Conference in San Francisco.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Biotech Showcase Conference will feature presentations by approximately 400 companies who will be discussing their product pipelines, technologies, services, and products.

Kintara’s webcast will be held on January 10, 2023 at 11:30 am PST.

Registered attendees may attend the presentation in-person or view it via webcast through the Biotech Showcase platform.